Design, synthesis, and biological evaluation of novel HDAC3 PROTACs for combined therapy with Venetoclax in acute myeloid leukemia.
1/5 보강
Acute myeloid leukemia (AML) is a heterogeneous hematopoietic neoplasm driven in part by aberrant epigenetic mechanisms such as histone deacetylation, with HDAC3 playing an important role in its patho
APA
Chen Y, Liu E, et al. (2026). Design, synthesis, and biological evaluation of novel HDAC3 PROTACs for combined therapy with Venetoclax in acute myeloid leukemia.. Bioorganic chemistry, 170, 109520. https://doi.org/10.1016/j.bioorg.2026.109520
MLA
Chen Y, et al.. "Design, synthesis, and biological evaluation of novel HDAC3 PROTACs for combined therapy with Venetoclax in acute myeloid leukemia.." Bioorganic chemistry, vol. 170, 2026, pp. 109520.
PMID
41610583 ↗
Abstract 한글 요약
Acute myeloid leukemia (AML) is a heterogeneous hematopoietic neoplasm driven in part by aberrant epigenetic mechanisms such as histone deacetylation, with HDAC3 playing an important role in its pathogenesis. In this study, we designed a series of novel HDAC3 PROTACs based on our previously designed HDAC3 inhibitor as the POI ligand. Among these, representative compound B22 potently degraded HDAC3, with a DC of 30.73 nM and a D of 82%. B22 synergized with the clinically approved AML agent Venetoclax, demonstrating potent anti-proliferative effects and significantly promoting apoptosis in MV4-11 cells. Mechanistically, the combination of B22 and Venetoclax synergistically induces DNA damage and downregulates the anti-apoptotic proteins Mcl-1 and Bcl-xL. In conclusion, this study provided insights into novel HDAC3-directed PROTACs development and proposed their therapeutic potential against AML.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Leukemia
- Myeloid
- Acute
- Sulfonamides
- Histone Deacetylases
- Histone Deacetylase Inhibitors
- Drug Design
- Bridged Bicyclo Compounds
- Heterocyclic
- Antineoplastic Agents
- Cell Proliferation
- Structure-Activity Relationship
- Drug Screening Assays
- Antitumor
- Molecular Structure
- Apoptosis
- Dose-Response Relationship
- Drug
- Cell Line
- Tumor
- Proteolysis Targeting Chimera
- Acute myeloid leukemia
- Combined therapy
… 외 2개
같은 제1저자의 인용 많은 논문 (5)
- A New Algorithm for Secondary Repair of Unilateral Cleft Lip Nasal Deformity.
- Machine-Learning Prediction of Capsular Contraction after Two-Stage Breast Reconstruction.
- DIAPH3 is a multifaceted prognostic biomarker that links immunotherapy response to tumor microenvironment in prostate cancer.
- The Exosome-Lactate-Lactylation Axis: A Metabolic-Epigenetic Circuit Driving Tumor Immune Evasion.
- LncRNAs: key regulators and molecular mechanisms in lung cancer radiosensitivity.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.